Opfolda 71904-0300-03

Generic: Miglustat

Package NDC

71904-0300-03

Product NDC: 71904-0300

Manufacturer: Amicus Therapeutics Us, Llc
Dosage Form: Capsule
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: October 11, 2023
Listing Expires: December 31, 2026
Application: NDA215211

Need to source Opfolda? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Miglustat	65 mg/1

Drug Class

Glucosylceramide Synthase Inhibitor [EPC]Enzyme Stabilizer [EPC]Enzyme Stabilizer [EPC]

Selected Package

71904-0300-03Selected

100 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-03) / 1 CAPSULE in 1 BOTTLE, PLASTIC

Other packages for this product(2)

71904-0300-01

4 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-01) / 1 CAPSULE in 1 BOTTLE, PLASTIC

View →

71904-0300-02

24 BOTTLE, PLASTIC in 1 BOTTLE, PLASTIC (71904-300-02) / 1 CAPSULE in 1 BOTTLE, PLASTIC

View →